Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- Check7 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the 2026-04-03 update; 2026-03-20 content was deleted.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded Contacts/Locations and Study Status entries; a deletion occurred on 2026-03-06.SummaryDifference0.2%

- Check28 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and the previous v3.4.3 entry was removed from the record history.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded Contacts/Locations and Study Status sections to the record history page and updated to Revision: v3.4.3.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a new Study Status entry on 2026-02-06. Removed the government funding lapse notice.SummaryDifference0.5%

- Check71 days agoChange DetectedA site-wide government funding notice was added at the top, and a new page revision tag (Revision: v3.4.1) was introduced. The prior revision tag (Revision: v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.